MedTrace Logo

Hypertonic Lactate After Cardiac Arrest

NCT05004610 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2025-02-21

No results posted yet for this study

Summary

The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.

Conditions

  • Cardiac Arrest
  • Ischemia Reperfusion Injury
  • Anoxic Brain Injury

Interventions

DRUG

Sodium Lactate Solution

continuous intravenous infusion of molar sodium lactate

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Filippo Annoni, MD · H.U.B Erasme

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-19
Primary Completion
2027-12-31
Completion
2028-05-15

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05004610 on ClinicalTrials.gov